Omada Health, Inc.
OMDA
$18.32
$0.442.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 78.05M | 75.85M | 68.03M | 61.37M | 54.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.05M | 75.85M | 68.03M | 61.37M | 54.96M |
| Cost of Revenue | 29.36M | 22.18M | 22.96M | 21.07M | 23.06M |
| Gross Profit | 48.69M | 53.66M | 45.07M | 40.31M | 31.90M |
| SG&A Expenses | 40.78M | 38.83M | 37.28M | 34.63M | 31.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 82.83M | 72.57M | 70.54M | 65.72M | 63.36M |
| Operating Income | -4.78M | 3.28M | -2.51M | -4.34M | -8.40M |
| Income Before Tax | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M |
| EBIT | -4.78M | 3.28M | -2.51M | -4.34M | -8.40M |
| EBITDA | -3.27M | 4.73M | -1.15M | -2.99M | -7.06M |
| EPS Basic | -0.05 | 0.09 | -0.06 | -0.24 | -1.15 |
| Normalized Basic EPS | -0.03 | 0.06 | -0.01 | -0.15 | -0.72 |
| EPS Diluted | -0.05 | 0.08 | -0.06 | -0.24 | -1.15 |
| Normalized Diluted EPS | -0.03 | 0.05 | -0.01 | -0.15 | -0.72 |
| Average Basic Shares Outstanding | 58.92M | 58.06M | 57.66M | 21.97M | 8.24M |
| Average Diluted Shares Outstanding | 58.92M | 63.93M | 57.66M | 21.97M | 8.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |